Hetero Labs Ltd., Hetero Drugs Ltd., Hetero Biopharma Ltd., Annora Pharma Private Ltd., Aspiro Pharma Ltd.

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022-04 to 2023-03🗂️ Report periods on file: 2022-04 to 2023-03, 2021-04 to 2022-03, 2019-04 to 2020-03

In its 2022-04 to 2023-03 reporting, Hetero Labs Ltd., Hetero Drugs Ltd., Hetero Biopharma Ltd., Annora Pharma Private Ltd., Aspiro Pharma Ltd. disclosed greenhouse gas emissions of 213.3K tCO2e/year. By scope: Scope 1: 188.3K tCO2e/year; Scope 2: 199.1K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
213.3K tCO2e/year
2022-04 to 2023-03
⚡
Renewable Energy
22.23% (based on total energy consumed)
of total energy
💧
Water Usage
974 ML/year
2022-04 to 2023-03
♻️
Waste
28.6K MT/year
2022-04 to 2023-03
⚙️
Energy Use
4.0K TJ/year
2022-04 to 2023-03

📊 Emissions by Scope (2022-04 to 2023-03)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).188.3K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.199.1K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2022-04 to 2023-03213.3K tCO2e/year
2021-04 to 2022-03461.7K tCO2e/year (Scope 1 and 2)
2019-04 to 2020-03402.4K tCO2e/year (Scope 1 & 2)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce carbon emissions (Scope 1 & 2) – 25% by 2030 (base year 2022)
  • Improve the percentage of women employees to 10% by 2026
  • Increase wastewater recycling by 5% annually
  • Assess 80% critical suppliers for ESG compliance by 2028

📅 Medium-term

  • Establish Scope 3 inventory by 2030
  • Increase renewable energy sources by 30% by 2030
  • Undertake water stress and risk assessment by FY 2030
  • Set up ISO31000 Risk Management Processes by 2028

🔭 Long-term

  • Achieve net-zero emissions by 2045
  • Become Zero Waste to Landfill Company by 2030

🌱 ESG Focus Areas

Climate ChangeWater StewardshipWaste ManagementEmployee Well-beingDiversity & InclusionSupply Chain ResponsibilityGovernanceDrug SafetyHuman RightsProduct Quality and SafetyLabor RelationsIndirect Economic ImpactAccess to Medicine at Affordable Prices

⚠️ Challenges & Risks +

  • Water stress in operating locations
  • Increased waste generation due to expansion and product mix
  • Increased attrition rate (44% increase over previous year)

📋 Report Information

Reporting Period: 2022-04 to 2023-03
Frameworks: GRI Standards 2021, UNGC Principles, UN SDGs
Assurance: TUV India